Cargando…

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States

BACKGROUND: Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend triple therapy (TT) for chronic obstructive pulmonary disease (COPD) patients based on severity. TT utilization by severity is infrequently studied in real-world settings and may deviate significantly from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schabert, Vernon, Shah, Surbhi, Holmgren, Ulf, Cabrera, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058794/ https://www.ncbi.nlm.nih.gov/pubmed/33866875 http://dx.doi.org/10.1177/17534666211001018

Ejemplares similares

Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK
por: Quint, Jennifer K, et al.
Publicado: (2020)

Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease
por: Quint, Jennifer K., et al.
Publicado: (2020)

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
por: de Nigris, Enrico, et al.
Publicado: (2022)

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease
por: Cook, Jennifer, et al.
Publicado: (2021)

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
por: Evans, Kristin A, et al.
Publicado: (2022)

Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Chronic Obstructive Pulmonary Disease and Smoking Status — United States, 2017
por: Wheaton, Anne G., et al.
Publicado: (2019)

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States
por: Diette, Gregory B, et al.
Publicado: (2015)

Chronic Obstructive Pulmonary Disease Mortality by Industry and Occupation — United States, 2020
por: Syamlal, Girija, et al.
Publicado: (2022)

Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model
por: Bogart, Michael, et al.
Publicado: (2022)

Urban-Rural County and State Differences in Chronic Obstructive Pulmonary Disease — United States, 2015
por: Croft, Janet B., et al.
Publicado: (2018)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
por: Brusselle, Guy, et al.
Publicado: (2015)

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
por: Zheng, Yayuan, et al.
Publicado: (2018)

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021)

Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
por: Valvi, Deepa, et al.
Publicado: (2012)

Duration of corticosteroid use in chronic obstructive pulmonary disease exacerbations: improving prescribing practices on clinical teaching units with peer-to-peer teaching
por: Matte, Catherine, et al.
Publicado: (2018)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study
por: Boggon, Rachael, et al.
Publicado: (2013)

Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease
por: Souliotis, Kyriakos, et al.
Publicado: (2016)

Employment and Activity Limitations Among Adults with Chronic Obstructive Pulmonary Disease — United States, 2013
por: Wheaton, Anne G., et al.
Publicado: (2015)

Are Rural Residence and Poverty Independent Risk Factors for Chronic Obstructive Pulmonary Disease in the United States?
por: Wei, Ran
Publicado: (2019)

Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
por: Westney, Gloria, et al.
Publicado: (2017)

The Impact of Hepatic Cirrhosis on Chronic Obstructive Pulmonary Disease in the United States: A Nationwide Analysis
por: Pellegrini, James R, et al.
Publicado: (2021)

Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments, 2010–2018
por: Liew, Chiat Qiao, et al.
Publicado: (2023)

Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed
por: Nastałek, Paweł, et al.
Publicado: (2018)

Trends in the Use, Sociodemographic Correlates, and Undertreatment of Prescription Medications for Chronic Obstructive Pulmonary Disease among Adults with Chronic Obstructive Pulmonary Disease in the United States from 1999 to 2010
por: Ford, Earl S., et al.
Publicado: (2014)

Patterns in Outpatient Benzodiazepine Prescribing in the United States
por: Agarwal, Sumit D., et al.
Publicado: (2019)

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease
por: Brunner, Wendy M., et al.
Publicado: (2022)

Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States
por: Holt, James B, et al.
Publicado: (2011)

Overlap of Asthma and Chronic Obstructive Pulmonary Disease in Patients in the United States: Analysis of Prevalence, Features, and Subtypes
por: Turner, Ralph M, et al.
Publicado: (2018)

United in Prevention–Electrocardiographic Screening for Chronic Obstructive Pulmonary Disease
por: Lazovic, Biljana, et al.
Publicado: (2013)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
por: Ferguson, Gary T, et al.
Publicado: (2020)

Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial
por: Halpin, David M. G., et al.
Publicado: (2020)

Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Wu, Benjamin, et al.
Publicado: (2022)

Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease
por: Easter, Molly, et al.
Publicado: (2020)

Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pqoigvr10j79hraho16hsdvt1g